{
    "id": 24078,
    "fullName": "POLE R114*",
    "impact": "nonsense",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "POLE R114* results in a premature truncation of the Pole protein at amino acid 114 of 2286 (UniProt.org). Due to the loss of most known functional domains (UniProt.org), R114* is predicted to lead to a loss of Pole protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5426,
        "geneSymbol": "POLE",
        "terms": [
            "POLE",
            "CRCS12",
            "FILS",
            "IMAGEI",
            "POLE1"
        ]
    },
    "variant": "R114*",
    "createDate": "07/07/2016",
    "updateDate": "07/07/2016",
    "referenceTranscriptCoordinates": {
        "id": 173031,
        "transcript": "NM_006231",
        "gDna": "chr12:g.132680037G>A",
        "cDna": "c.340C>T",
        "protein": "p.R114*",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7251,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case report, Keytruda (pembrolizumab) treatment resulted in quick clinical improvement and a partial response lasting over 14 months in a patient with endometrial adenocarcinoma that was PD-L1 (CD274)-positive, harbored POLE V411L and R114*, and had high tumor mutational burden (PMID: 27159395).",
            "molecularProfile": {
                "id": 31370,
                "profileName": "CD274 pos POLE R114* POLE V411L TMB high"
            },
            "therapy": {
                "id": 1447,
                "therapyName": "Pembrolizumab",
                "synonyms": null
            },
            "indication": {
                "id": 2870,
                "name": "endometrial adenocarcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 6260,
                    "pubMedId": 27159395,
                    "title": "Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27159395"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24806,
            "profileName": "POLE R114*",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 24807,
            "profileName": "CD274 pos POLE R114* POLE V411L",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 31370,
            "profileName": "CD274 pos POLE R114* POLE V411L TMB high",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 173031,
            "transcript": "NM_006231",
            "gDna": "chr12:g.132680037G>A",
            "cDna": "c.340C>T",
            "protein": "p.R114*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173033,
            "transcript": "XM_011534800",
            "gDna": "chr12:g.132680037G>A",
            "cDna": "c.340C>T",
            "protein": "p.R114*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173034,
            "transcript": "XM_011534799",
            "gDna": "chr12:g.132680037G>A",
            "cDna": "c.340C>T",
            "protein": "p.R114*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 173032,
            "transcript": "XM_011534795",
            "gDna": "chr12:g.132680037G>A",
            "cDna": "c.340C>T",
            "protein": "p.R114*",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}